RD&C developed a novel systemic analysis concept for impurity profiling in pharmaceutical drug process development and impurity related deviation management at development stage or in routine drug manufacturing.
Prof. Ulrike Holzgrabe (University Wuerzburg) and Helmut Buschmann (RD&C) published a recent article in DAZ on Remifentanil
Concept Heidelberg/ECA invited Helmut Buschmann and Norbert Handler to give talks for the workshop "Stability by Design". The 2-day course was held in Berlin 4. and 5. April with 35 participants.
The method could be used for prediction of stability, polymorph changes, shelf-life, degradations in solid environment as well as development tool for solid formulations. The service is offered to customers, but is also open for out-licensing.
This accredited chartered engineer status warrants fitness for combining a broad technical background with an objective view, directed towards protecting the clients’ interests and ensuring superior performance at the lowest commensurate cost. Chartered engineer status ensures quality, employability and professional recognition.
The expert status is announced for 5 years comprises the fields pharmaceutical chemistry, pharmaceutical products and cosmetics.
RD&C team was responsible for section 2 "Drug Discovery Technologies". The book is in press and will be published in June 17.